Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)
China
· Delayed Price · Currency is CNY 37.08
+2.98 (8.74%)
Mar 11, 2026, 9:25 AM CST
SHE:300683 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 169.54 | 419.15 | 510.22 | 748.48 | 184.05 | 460.82 | Upgrade
|
| Short-Term Investments | - | 4.56 | 0.3 | 142.75 | 491.39 | 288.73 | Upgrade
|
| Trading Asset Securities | 526.22 | 449.69 | 578.71 | 144.04 | 514.4 | 250.39 | Upgrade
|
| Cash & Short-Term Investments | 695.75 | 873.4 | 1,089 | 1,035 | 1,190 | 999.94 | Upgrade
|
| Cash Growth | -20.72% | -19.81% | 5.21% | -12.99% | 18.99% | -14.91% | Upgrade
|
| Accounts Receivable | 309.35 | 300.78 | 254.58 | 233.21 | 264.48 | 231.6 | Upgrade
|
| Other Receivables | 3.95 | 0 | 0 | - | 3.18 | 0.45 | Upgrade
|
| Receivables | 313.3 | 300.78 | 254.58 | 233.21 | 270.15 | 235.28 | Upgrade
|
| Inventory | 85.39 | 108.98 | 117.41 | 120.18 | 71.65 | 69.63 | Upgrade
|
| Other Current Assets | 34.29 | 23.18 | 26.98 | 55.47 | 50.88 | 23.44 | Upgrade
|
| Total Current Assets | 1,129 | 1,306 | 1,488 | 1,444 | 1,583 | 1,328 | Upgrade
|
| Property, Plant & Equipment | 677.93 | 729.69 | 734.56 | 654.23 | 519.63 | 348.63 | Upgrade
|
| Long-Term Investments | 35.09 | 16.58 | 27.08 | 88.89 | 65.29 | 5 | Upgrade
|
| Goodwill | 178.59 | 263.59 | 263.59 | 302.15 | 316.17 | 316.45 | Upgrade
|
| Other Intangible Assets | 235.29 | 253.44 | 276.88 | 90.37 | 90 | 95 | Upgrade
|
| Long-Term Deferred Tax Assets | 127.75 | 119.94 | 109.47 | 80.59 | 71.64 | 57.63 | Upgrade
|
| Long-Term Deferred Charges | 30.88 | 34.49 | 31.96 | 2.62 | 2.39 | 2.61 | Upgrade
|
| Other Long-Term Assets | 222.71 | 212.57 | 39.51 | 43.87 | 49.87 | 32.96 | Upgrade
|
| Total Assets | 2,637 | 2,937 | 2,971 | 2,707 | 2,698 | 2,187 | Upgrade
|
| Accounts Payable | 43.52 | 64.35 | 52.08 | 58.05 | 51.72 | 50.6 | Upgrade
|
| Accrued Expenses | 14.59 | 79.11 | 59.86 | 46.51 | 46.42 | 37.49 | Upgrade
|
| Short-Term Debt | 7.14 | 7.22 | 7.32 | 30.03 | 33.04 | 6.49 | Upgrade
|
| Current Portion of Long-Term Debt | - | 14.83 | 14.66 | 7.31 | 3.21 | - | Upgrade
|
| Current Portion of Leases | - | 5.12 | 4.8 | 0.7 | 1.87 | - | Upgrade
|
| Current Income Taxes Payable | 6.36 | 3.87 | 2.84 | 2.46 | 4.52 | 2.45 | Upgrade
|
| Current Unearned Revenue | 53.08 | 77.54 | 116 | 97.99 | 66.38 | 44.68 | Upgrade
|
| Other Current Liabilities | 120.81 | 111.21 | 88.58 | 41.68 | 42.09 | 225.59 | Upgrade
|
| Total Current Liabilities | 245.49 | 363.26 | 346.15 | 284.73 | 249.25 | 367.31 | Upgrade
|
| Long-Term Debt | - | 11.52 | 26.32 | 40.92 | 48.17 | - | Upgrade
|
| Long-Term Leases | 4.06 | 5.36 | 10.4 | 2.59 | 3.64 | - | Upgrade
|
| Long-Term Unearned Revenue | 84.26 | 84.25 | 30.47 | 27.9 | 22.59 | 21.94 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 13.36 | 14.74 | 16.48 | 13.11 | 7.25 | 7.94 | Upgrade
|
| Other Long-Term Liabilities | 45.92 | 45.92 | 45.92 | 2.45 | 23.56 | 64.43 | Upgrade
|
| Total Liabilities | 393.09 | 525.05 | 475.73 | 371.7 | 354.46 | 461.62 | Upgrade
|
| Common Stock | 130.89 | 130.89 | 130.89 | 122.1 | 122.1 | 103.36 | Upgrade
|
| Additional Paid-In Capital | 1,837 | 1,837 | 1,837 | 1,557 | 1,557 | 987.76 | Upgrade
|
| Retained Earnings | 265.83 | 423.98 | 510.34 | 631.16 | 645.19 | 617.54 | Upgrade
|
| Total Common Equity | 2,234 | 2,392 | 2,478 | 2,310 | 2,324 | 1,709 | Upgrade
|
| Minority Interest | 10.25 | 19.8 | 17.37 | 24.79 | 18.65 | 16.29 | Upgrade
|
| Shareholders' Equity | 2,244 | 2,412 | 2,496 | 2,335 | 2,343 | 1,725 | Upgrade
|
| Total Liabilities & Equity | 2,637 | 2,937 | 2,971 | 2,707 | 2,698 | 2,187 | Upgrade
|
| Total Debt | 11.19 | 44.05 | 63.5 | 81.55 | 89.92 | 6.49 | Upgrade
|
| Net Cash (Debt) | 684.56 | 829.35 | 1,026 | 953.73 | 1,100 | 993.45 | Upgrade
|
| Net Cash Growth | -17.07% | -19.14% | 7.55% | -13.29% | 10.72% | -15.46% | Upgrade
|
| Net Cash Per Share | 5.29 | 6.34 | 7.90 | 7.48 | 10.34 | 9.53 | Upgrade
|
| Filing Date Shares Outstanding | 130.89 | 130.89 | 130.89 | 122.1 | 122.1 | 103.36 | Upgrade
|
| Total Common Shares Outstanding | 130.89 | 130.89 | 130.89 | 122.1 | 122.1 | 103.36 | Upgrade
|
| Working Capital | 883.24 | 943.07 | 1,142 | 1,159 | 1,333 | 960.99 | Upgrade
|
| Book Value Per Share | 17.06 | 18.27 | 18.93 | 18.92 | 19.04 | 16.53 | Upgrade
|
| Tangible Book Value | 1,820 | 1,875 | 1,938 | 1,918 | 1,918 | 1,297 | Upgrade
|
| Tangible Book Value Per Share | 13.90 | 14.32 | 14.80 | 15.71 | 15.71 | 12.55 | Upgrade
|
| Buildings | - | 500.14 | 500.38 | 398.72 | 350.14 | 174.04 | Upgrade
|
| Machinery | - | 528.75 | 480.61 | 339.05 | 291.83 | 228.39 | Upgrade
|
| Construction In Progress | - | 11.02 | 2.99 | 120.99 | 34.27 | 80.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.